ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Idali, F.
Right arrow Articles by Grunewald, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Idali, F.
Right arrow Articles by Grunewald, J.
Eur Respir J 2006; 27:451-459
Copyright ©ERS Journals Ltd 2006

Reduced Th1 response in the lungs of HLA-DRB1*0301 patients with pulmonary sarcoidosis

F. Idali1, M. Wikén1, J. Wahlström1, H. Mellstedt2, A. Eklund1, H. Rabbani3 and J. Grunewald1

1 Dept of Medicine, Division of Respiratory Medicine, 3 Immune and Gene Therapy Laboratory, Cancer Center Karolinska, 2 Dept of Oncology and Pathology, Karolinska University Hospital, Stockholm, Sweden.

CORRESPONDENCE: F. Idali, Dept of Medicine, Division of Respiratory Medicine, Lung Research Laboratory, L4:01, Karolinska University Hospital, Solna, 171 76 Stockholm, Sweden. Fax: 46 851775451. E-mail: Farah.Idali{at}medks.ki.se

Keywords: Bronchoalveolar lavage, cytokine, interferon-{gamma}, tumour necrosis factor-{alpha}, sarcoidosis

Received: June 8, 2005
Accepted November 22, 2005

To investigate why human leukocyte-associated antigen-DRB1*0301 (HLA-DRB1*0301) positive Scandinavian patients have a better prognosis than HLA-DRB1*0301 negative patients, the present authors examined patterns of cytokine expression in bronchoalveolar lavage (BAL) cells and BAL fluid (BALF) from patients with pulmonary sarcoidosis and controls.

Using real-time PCR, the mRNA expression of selected cytokines in BAL cells from newly diagnosed, untreated nonsmoking patients (n = 25) and controls (n = 11) was quantified. Cytokine protein levels in BALF from patients (n = 34) and controls (n = 11) were assessed using cytometric bead array. The patients were evaluated and stratified into two subgroups: HLA-DRB1*0301 positive (all with an acute onset) and HLA-DRB1*0301 negative (all with an insidious onset).

When comparing patients and controls, BAL cells of the patients expressed significantly higher levels of interferon (IFN)-{gamma} and interleukin (IL)-10 mRNA. There were significantly decreased IFN-{gamma} and tumour necrosis factor (TNF)-{alpha} mRNA levels, and a tendency toward higher levels of transforming growth factor-ß1 mRNA in HLA-DRB1*0301 positive compared with HLA-DRB1*0301 negative patients. Protein levels of IL-1ß, IL-2, IL-6, IL-12p70 and TNF-{alpha} in BALF were significantly higher in patients. HLA-DRB1*0301 positive patients exhibited tendencies to lower levels of most cytokines in BALF.

In conclusion, the present data show a reduced expression of T-helper cell type-1 cytokines in human leukocyte-associated antigen-DRB1*0301 positive patients, which may relate to their good prognosis.




This article has been cited by other articles:


Home page
NEJMHome page
M. C. Iannuzzi, B. A. Rybicki, and A. S. Teirstein
Sarcoidosis
N. Engl. J. Med., November 22, 2007; 357(21): 2153 - 2165.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. C. Iannuzzi and R. P. Baughman
Reverse Phenotyping in Sarcoidosis
Am. J. Respir. Crit. Care Med., January 1, 2007; 175(1): 4 - 5.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the European Respiratory Society.